Skip to main content

Nonprofit · EIN 16-0836536

MARY M GOOLEY HEMOPHILIA CENTER INC

Tax-exempt · ROCHESTER, NY 14621

Financials

$25.4M$19.9M2023$28.7M$21.5M2024
Revenue Expenses · by fiscal year end
Financials of MARY M GOOLEY HEMOPHILIA CENTER INC by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2024990$28,668,468$21,549,268$7,119,200$35,957,224$3,273,273$32,683,951
December 31, 2023990$25,362,099$19,865,599$5,496,500$28,705,288$3,347,755$25,357,533
Financial details: 990 for the year ended December 31, 2024

Revenue

Contributions, gifts and grants
$132,920
Program service revenue
$27,016,530
Investment income
$1,517,643
Net gain from sales of assets
$762,821
Net income from fundraising events
$1,375
Other revenue
$1,375

Expenses

Grants and similar amounts paid
$0
Compensation of officers, directors and key employees
$657,425
Other salaries and wages
$518,924
Salaries, compensation and benefits (total)
$1,430,948
Professional fundraising fees
$0
Legal fees
$4,384
Accounting fees
$20,400
Occupancy
$145,228
Depreciation
$58,415
Program services (functional)
$20,889,404
Management and general (functional)
$572,481
Fundraising (functional)
$87,383

Balance sheet and other

Total assets, start of year
$28,705,288
Total assets, end of year
$35,957,224
Total liabilities, end of year
$3,273,273
Net assets, end of year
$32,683,951
Land, buildings and equipment
$257,758
Publicly traded securities
$28,061,501
Net assets without donor restrictions
$32,575,447
Net assets with donor restrictions
$108,504
Gross receipts
$33,891,293
Employees
10
Volunteers
14
Year formed
1959
State of legal domicile
NY

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended December 31, 2024, highest compensation first.

NameTitleHours / weekCompensationOther / benefits
THOMAS WILMARTHPRESIDENT & CEO
Officer
40$213,886$14,530
GREGORY LIGHTHOUSE CPACFO
Officer
40$174,803$21,065
ERIC IGLEWSKI LMSWVP OF CLINICAL SERVICES
Highest-paid employee
40$146,970$24,556
TARA VEITH MSN FNP-CNURSE PRACTITIONER
Highest-paid employee
40$132,691$1,613
SAMANTHA VITAGLIANO DMDFORMER CHAIRPERSON
Trustee or director
1$1,000$0
NICHOLAS FARRIS MDBOARD MEMBER
Trustee or director
1$0$0
ROBIN REID MDNON-VOTING BOARD MEMBER
Trustee or director
1$0$0
RONALD SHAM MDBOARD MEMBER
Trustee or director
1$0$0
DAN GURELLTREASURER
Trustee or director, Officer
1$0$0
CHRISTINE HAY MDSECRETARY
Trustee or director, Officer
1$0$0
ANDREW PARKCHAIRPERSON
Trustee or director, Officer
1$0$0
LARRY DENK MDBOARD MEMBER
Trustee or director
1$0$0
PETER KOUIDES MDNON-VOTING BOARD MEMBER
Trustee or director
1$0$0
TIMOTHY ABBAMONTE DDSBOARD MEMBER
Trustee or director
1$0$0
990 for the year ended December 31, 2023: 13 people
NameTitleHours / weekCompensationOther / benefits
THOMAS WILMARTHPRESIDENT & CEO
Officer
40$206,914$34,791
GREGORY LIGHTHOUSE CPACFO
Officer
40$151,965$20,277
ERIC IGLEWSKI LMSWVP OF CLINICAL SERVICES
Highest-paid employee
40$133,994$21,619
TARA VEITH MSN FNP-CNURSE PRACTITIONER
Highest-paid employee
40$104,780$5,636
SAMANTHA VITAGLIANO DMDCHAIRPERSON
Trustee or director, Officer
1$1,000$0
AKUA ASANTE MDBOARD MEMBER
Trustee or director
1$0$0
KHARI SABBBOARD MEMBER
Trustee or director
1$0$0
RONALD SHAM MDBOARD MEMBER
Trustee or director
1$0$0
DAN GURELLTREASURER
Trustee or director, Officer
1$0$0
CHRISTINE HAY MDBOARD MEMBER
Trustee or director
1$0$0
ANDREW PARKSECRETARY
Trustee or director, Officer
1$0$0
LARRY DENK MDBOARD MEMBER
Trustee or director
1$0$0
PETER KOUIDES MDNON-VOTING BOARD MEMBER
Trustee or director
1$0$0

Address and contacts

Address (IRS master file)
1415 PORTLAND AVE STE 500, ROCHESTER, NY 14621-3043
Principal officer (990 for 2024)
THOMAS WILMARTH, 1415 PORTLAND AVE 500, ROCHESTER, NY 14621
Signed the 990
THOMAS WILMARTH, PRESIDENT & CEO
Phone
(585) 922-5700
Return prepared by
BONADIO & CO LLP

Mission

TO PROVIDE EDUCATION, TREATMENT, RESEARCH, ADVOCACY AND SUPPORTIVE PROGRAMS TO IMPROVE THE LIVES OF PEOPLE AFFECTED BY BLEEDING DISORDERS AND IRON OVERLOAD.

990 for the year ended December 31, 2024

Program accomplishments

  • THE CENTER HAS APPROXIMATELY 366 BLEEDING DISORDER PATIENTS ON ITS ACTIVE CASELOAD. IN 2024, 231 UNIQUE PATIENTS WITH HEMOPHILIA, VON WILLEBRAND DISEASE AND OTHER RARE CLOTTING DEFICIENCIES WERE EVALUATED AND TREATED. 66 PATIENTS WITH MODERATE AND SEVERE HEMOPHILIA ATTEND SPECIALIZED COMPREHENSIVE CARE CLINICS AT LEAST ONCE EACH YEAR, RECEIVING CONSULTATION FROM AN ONSITE HEMATOLOGIST, NURSE COORDINATOR, SOCIAL WORKER, PHYSICAL THERAPIST, ORTHOPEDIC SURGEON AND DENTIST. THE CENTER HAS AN ON-SITE SPECIALTY PHARMACY THAT PROVIDES CLOTTING FACTOR TO 52 HEMOPHILIA PATIENTS VIA OUR HOME INFUSION PROGRAM.
    Expenses $20,420,756 · revenue $26,981,763
  • THE CENTER PROVIDES SPECIALIZED EVALUATION AND CARE FOR PATIENTS WITH HEREDITARY HEMOCHROMATOSIS AND IRON OVERLOAD. TYPICALLY, PATIENTS WITH THESE CONDITIONS RECEIVE REGULAR THERAPEUTIC PHLEBOTOMIES TO DIMINISH EXCESS IRON STORED IN THEIR BODIES, DIMINISHING RISK OF PERMANENT ORGAN DAMAGE. THE CENTER SERVES APPROXIMATELY 213 HEMOCHROMATOSIS/IOD PATIENTS.
    Expenses $314,047 · revenue $34,767
  • THE CENTER HAS BEEN ACTIVELY INVOLVED IN RESEARCH AND CLINICAL TRIALS IN AN EFFORT TO CULTIVATE ADVANCES IN HEMOPHILIA, VON WILLEBRAND DISEASE AND HEMOCHROMATOSIS. IN 2024, THE CENTER PARTICIPATED IN 2 OPEN RESEARCH STUDIES ADDRESSING A WIDE RANGE OF CLINICAL AREAS AND OUTCOMES. IN ADDITION, THE CENTER WORKS CLOSELY WITH THE CENTER FOR DISEASE CONTROL (CDC) AND THE AMERICAN THROMBOSIS AND HEMOSTASIS NETWORK (ATHN) REGISTRIES, COLLECTING DATA AS PART OF A NATIONAL EFFORT TO BETTER UNDERSTAND AND CARE FOR RARE BLEEDING DISORDERS.
    Expenses $72,743
  • REVENUES AND EXPENSES FOR NATIONAL HEMOPHILIA FOUNDATION CHAPTER ACTIVITIES.
    Expenses $81,858

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026Not on file
2024December 31, 2024May 15, 2025990 on file
2023December 31, 2023May 15, 2024990 on file

IRS record

EIN
16-0836536
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (509(a)(2))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
1983
Accounting year ends
December
Files
Form 990 or 990-EZ
Assets (IRS master file)
$35,957,224
Income (IRS master file)
$33,891,293

Filing history

FormYear endedRevenueExpensesAssetsReturn
990December 2024$28,668,468$21,549,268$35,957,224IRS
990December 2023$25,362,099$19,865,599$28,705,288XML
990December 2022$23,562,520$18,876,090$22,291,698IRS
990December 2021–––IRS
990December 2020–––IRS
990December 2018–––IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 16-0836536).

Questions about MARY M GOOLEY HEMOPHILIA CENTER INC

What is the EIN of MARY M GOOLEY HEMOPHILIA CENTER INC?
The employer identification number (EIN) of MARY M GOOLEY HEMOPHILIA CENTER INC is 16-0836536.
Is MARY M GOOLEY HEMOPHILIA CENTER INC tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 1983.
Are donations to MARY M GOOLEY HEMOPHILIA CENTER INC tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does MARY M GOOLEY HEMOPHILIA CENTER INC file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of MARY M GOOLEY HEMOPHILIA CENTER INC due?
The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
When did MARY M GOOLEY HEMOPHILIA CENTER INC last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended December 2024.
Who is the principal officer of MARY M GOOLEY HEMOPHILIA CENTER INC?
The 990 for the year ended December 31, 2024 names THOMAS WILMARTH.
Who are the officers and directors of MARY M GOOLEY HEMOPHILIA CENTER INC?
The 990 for the year ended December 31, 2024 lists 14 people; 5 received compensation from the organization, the highest $213,886 (THOMAS WILMARTH, PRESIDENT & CEO).
How much revenue does MARY M GOOLEY HEMOPHILIA CENTER INC have?
On its 990 for the year ended December 31, 2024 it reported revenue of $28,668,468, expenses of $21,549,268 and total assets of $35,957,224 at year end.

Other nonprofits in ROCHESTER

All nonprofits in ROCHESTER · New York